Flow stabilizer on a syringe tip for hand-powered microfluidic sample injection

Lab on a Chip ◽  
2019 ◽  
Vol 19 (2) ◽  
pp. 214-222 ◽  
Author(s):  
Nan Xiang ◽  
Yu Han ◽  
Yuan Jia ◽  
Zhiguo Shi ◽  
Hong Yi ◽  
...  

We proposed a novel syringe flow-stabilizer for hand-powered, precise, continuous-flow microfluidic sample injection in resource-poor settings.

RSC Advances ◽  
2017 ◽  
Vol 7 (18) ◽  
pp. 10624-10630 ◽  
Author(s):  
Kieu The Loan Trinh ◽  
Wenming Wu ◽  
Nae Yoon Lee

The 3D spiral PTFE microdevice was fabricated for performing continuous-flow PCR using a single heater and via semi-automated sample injection method.


The Analyst ◽  
2012 ◽  
Vol 137 (4) ◽  
pp. 983-990 ◽  
Author(s):  
Wenming Wu ◽  
Kieu The Loan Trinh ◽  
Nae Yoon Lee

2020 ◽  
Vol 22 (19) ◽  
pp. 6437-6443
Author(s):  
Cheng-Kou Liu ◽  
Meng-Yi Chen ◽  
Xin-Xin Lin ◽  
Zheng Fang ◽  
Kai Guo

A catalyst-, oxidant-, acidic solvent- and quaternary ammonium salt-free electrochemical para-selective hydroxylation of N-arylamides at rt in batch and continuous-flow was developed.


2021 ◽  
Vol 147 (3) ◽  
pp. 04021002
Author(s):  
Wenrui Qu ◽  
Shaojie Liu ◽  
Qun Zhao ◽  
Yi Qi

JMS SKIMS ◽  
2020 ◽  
Vol 23 (1) ◽  
pp. 3-15
Author(s):  
Saleem Kamili ◽  
Hisham Qadri

Hepatitis C, caused by hepatitis C virus (HCV) was originally described as parenterally transmitted non-A non-B hepatitis. Since its discovery in 1989, the field of HCV research has become a shining example of successful translation of basic research wherein in a short of span of just 30 years the virus was discovered, highly sensitive and specific diagnostic assays were developed, epidemiology and clinical characteristics of the disease were well defined and now with the availability of highly efficacious antiviral therapies many countries are already on their way to achieving World Health Organization’s (WHO) elimination targets of hepatitis C by 2030.  However, much work needs to be done to eliminate hepatitis C especially in resource poor countries. Most recent data show an estimated 71 million people are currently infected with HCV worldwide and approximately 400,000 people die each year from causes related to HCV. Of these estimates, more than 13 million HCV infected persons are in India and Pakistan (Figure 1). Despite the availability of a cure for hepatitis C, only 20% of those infected patients have been diagnosed (1). In order to achieve the WHO targets of hepatitis C elimination, concerted efforts will have to made to make affordable and reliable diagnostics available worldwide.


Sign in / Sign up

Export Citation Format

Share Document